Summary: Luxor Scientific has developed advanced testing solutions to address the nation’s overdose crises related to substances like bromazolam, tianeptine, xylazine, and nitazenes, providing healthcare professionals with critical information for more effective treatment plans.

Takeaways:

  1. Luxor Scientific’s testing solutions can accurately detect over 100 drugs and metabolites, including novel illicit substances, using urine and oral fluid samples.
  2. These tests provide rapid turnaround times, delivering life-saving results within 24 to 48 hours, essential for timely interventions in emergency situations.
  3. The precise detection capabilities and rapid response times of Luxor’s solutions empower healthcare professionals and stakeholders to address the overdose crisis effectively, safeguarding public health.

Luxor Scientific has developed advanced testing solutions to address the nation’s overdose crises associated with substances like bromazolam, tianeptine, xylazine, and nitazenes, providing healthcare professionals the information needed to develop more effective treatment plans.

Addressing the Illicit Drug Crisis

Bromazolam, often labeled as ‘Fake Xanax,’ is misrepresented as genuine Xanax, leading to a surge in overdose incidents and widespread concern among healthcare and law enforcement. Consumed orally to alleviate anxiety and panic, bromazolam’s availability online exacerbates the risk. 

Similarly, tianeptine, known as ‘gas station heroin,’ administered intravenously for a euphoric effect, has recently prompted Louisiana to ban it due to reports of seizures and loss of consciousness. Additionally, the emergence of xylazine, a potent horse tranquilizer mixed with fentanyl, exacerbates the crisis, causing zombie-like behavior in users.

Luxor’s New Testing Solution

Luxor Scientific’s new testing solutions mark a significant advancement in combating illicit drug proliferation, providing precise detection of hazardous substances in easily collected body fluids.

Using state-of-the-art technology and extensive toxicology experience, the company’s testing protocols empower stakeholders to respond effectively, safeguarding public health, according to the company. Luxor’s ability to detect illicit drug use in urine and oral fluid, along with rapid turnaround times, ensures life-saving results within 24 to 48 hours, critical for immediate intervention in emergency situations.

“As a leading force in scientific research and innovation, Luxor Scientific is committed to leveraging our expertise to address pressing societal challenges such as the proliferation of illicit drugs,” says Marion Snyder, PhD, chief science officer at Luxor Scientific. “Our cutting-edge testing solutions represent a significant milestone in our ongoing efforts to combat the devastating impact of substance use disorder, empowering communities with the tools needed to safeguard public health and effectively treat patients.”

Luxor Scientific has the capability to detect over 100 drugs and metabolites, including novel illicits, according to the company.